Prognostic factors of paediatric ALL valuable to clinical decision include clinical features at diagnosis, subtypes defined by cell lineage (e.g. T‐ALL and B‐ALL) and genetics (e.g. TCF3‐PBX1, MLL, etc.), and early response to induction therapy.2 This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.